EUVIMEDEUVIMED entdecken
Crossref

Neonate With a Diffuse Maculopapular and Nodular Rash

Danielle N Gonzales, Jyotinder Nain Punia, Monika S Patil

NeoReviews · 2024

DOI: 10.1542/neo.25-3-e232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeoReviews, 2024. Verfasst von Danielle N Gonzales und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, TX. Hauptthemen laut MEDLINE: Exanthema. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A full-term female infant is transferred from an outside hospital at 3 days of age for further evaluation of a diffuse maculopapular and nodular rash noted since birth. The rash covers the infant’s entire body.Born to a 37-year-old gravida 4, para 3 womanPregnancy uncomplicatedEstimated gestational age: 39 weeks 3 daysPrenatal maternal laboratory findings: Group B Streptococcus–negative; hepatitis B surface antigen–negative; HIV-nonreactive; rapid plasma reagin–negative; rubella-immune; COVID-negativeUncomplicated repeat cesarean delivery without need for resuscitation; no sepsis risk factorsApgar score: 8 and 8 at 1 and 5 minutes, respectivelyImmediately after delivery, the neonate was noted to have a diffuse maculopapular and nodular rash, prompting transfer to the NICU for further evaluation. The infant was otherwise well-appearing. While the infant was initially stable in room air, on the day of transfer she developed occasional desaturations, so she was placed on high-flow nasal cannula. An evaluation of the infant’s rash was initiated at the birth hospital and completed at the transfer hospital.Heart rate: 152 beats/minRespiratory rate: 80 breaths/minBlood pressure: 96/57 mm HgOxygen saturation: 97% (on 2 L/min high-flow nasal cannula)Temperature: 98.6°F (37.0°C)Birthweight: 3,230 g (50th percentile); birth length: 50.8 cm (81st percentile); birth head circumference: 35 cm (83rd percentile)Current weight: 3,300 g (45th percentile)General appearance: No acute distress, paleHead: Anterior fontanelle the size of a fingertip, periorbital edemaEyes: Normal red reflex bilaterallyNose: Stertor presentMouth: Palate intact, normal tongue, no oral lesions, normal suck, moist mucosaLungs: Clear, equal breath rounds. No retractions. Tachypnea presentCardiovascular: 2/6 systolic murmur heard best at left sternal border, 2+ brachial and femoral pulses present. Less than 2 second capillary refillNeurologic: Alert, calm, normal suck, rooting, grasp, and Moro reflexesExtremities: Moving all extremities, no abnormalitiesAbdomen: Nontender and non-distended, occasional bowel sounds, liver edge palpable about 2 to 3 cm below costal margin, spleen tip palpableGenitourinary: Normal term female genitalia, patent anusSkin: Scattered blue-hued nonblanching maculopapular and nodular rash on face, lower extremities, trunk and back, no petechiae (Fig 1)White blood cell count: 173 × 103/μL (173 × 109/L), absolute neutrophil count 0, monocyte predominancePlatelets: 73 × 103/μL (73 × 109/L)Hematocrit: 32%Blood culture negativeLactate dehydrogenase: 2,470 U/L (41.25 μkat/L)Uric acid: 7.8 mg/dL (0.46 mmol/L)Coagulation studies: Coagulation tests were unmeasurable initially. The infant was given fresh frozen plasma and cryoprecipitate. Repeat studies showed prothrombin time (PT) 17 seconds, partial thromboplastin time (PTT) 31.6 seconds, fibrinogen 70 mg/dL.White blood cell count: 124 × 103/μL (124 × 109/L)Platelets: 31 × 103/μL (31 × 109/L)Hematocrit: 31%Peripheral smear: SentPotassium 2.9 mEq/L (2.9 mmol/L)Bicarbonate 36 mEq/L (36 mmol/L)Calcium 12.0 mg/dL (2.99 mmol/L)Phosphorus 0.8 mg/dL (0.26 mmol/L)EuglycemicNormal renal functionLiver panel: NormalUric acid: 3.9 mg/dL (0.23 mmol/L)Lactate dehydrogenase: 1,615 U/L (27 μkat/L)Coagulation studies: Prothrombin time, 19.4 seconds; international normalized ratio, 1.6; partial thromboplastin time, 46.3 seconds; fibrinogen, 190 mg/dL (5.6 g/L)TORCH (toxoplasmosis, other infections, rubella, cytomegalovirus infection, and herpes simplex) studies: SentChest radiography: Clear lung fields without evidence of atelectasis, consolidation, edema, or fluid in the fissuresHead ultrasonography: Possible left grade 1 germinal matrix hemorrhage, bilateral lenticulostriate vasculopathy; no calcificationsAbdominal ultrasonography (due to hepatomegaly on examination): Diffuse periportal edema, no liver mass, borderline splenomegaly, no bile duct dilationEchocardiography: Small patent ductus arteriosus, moderate atrial septal defect with left-to-right shunting, mild to moderate right ventricular dilation, moderately dilated right atrium, normal biventricular functionA 3-day-old full-term appropriate-for–gestational age female presents with a blue-hued diffuse maculopapular and nodular rash present since birth, leukocytosis with monocyte predominance, thrombocytopenia, anemia, and coagulopathy.Aicardi-Goutières syndromeCongenital leukemiaHemangiomatosisLangerhans cell histiocytosisRhabdomyosarcomaTORCH infectionsThe findings of anemia, thrombocytopenia, and blue-hued maculopapular and nodular rash were concerning for congenital leukemia. The infant also had leukocytosis. The peripheral blood smear showed numerous blasts. Most of the blasts were large in size, with a high nuclear to cytoplasmic ratio, moderate basophilic cytoplasm, fine chromatin, occasional prominent nucleoli, and round/indented nuclear contours. No Auer rods were seen. Occasional blasts were small in size (example of different patient with similar findings shown in Fig 2). Flow cytometry of the peripheral blood showed 2 distinct populations of blasts (Fig 3). The major population (red colored in flow plots) was marked as monocytic, and pertinent positive markers were CD33, CD11b, CD64, CD14 (partial) and cytoplasmic myeloperoxidase. The monocytic population explains the monocyte predominance noted on the original complete blood cell count. The minor population (brown colored in flow plots) was marked as immature B cells, and pertinent positive markers were CD19, CD22, CD34, and cytoplasmic CD79a. Overall, this was consistent with a mixed phenotype acute leukemia (MPAL; B/monocytic), KMT2A rearrangement was detected via fluorescence in situ hybridization analysis.The patient was given chemotherapy consisting of cytarabine, daunorubicin, and dexrazoxane, as well as intrathecal chemotherapy (methotrexate, hydrocortisone and cytarabine). Complications included tumor lysis syndrome requiring rasburicase and allopurinol; mucositis and gastritis requiring octreotide and pantoprazole; cerebral hemorrhage; coagulase-negative Staphylococcus bacteremia; and pulmonary Aspergillus infection (positive metagenomic next-generation sequencing assay and evidence of pulmonary nodules on computed tomography). She required occasional intubations for procedures, and oxygen for the remaining time due to multiple factors (infection, fluid overload). Following induction chemotherapy, she had evidence of blasts consistent with persistent/relapsed disease. Despite multiple chemotherapy induction cycles, her leukemia progressed and spread into the central nervous system with evidence of blasts on regularly scheduled lumbar punctures. At that point, the family made the difficult decision to transition to comfort care and this patient ultimately died surrounded by loved ones at 5 months of age.There are many types and subtypes of leukemia depending on cell lineage, cell morphology, genetic findings, etc. Broadly, World Health Organization classification categorizes hematopoietic neoplasms into 3 categories based on lineage: myeloid, lymphoid, and histiocyte/dendritic. They are then subdivided by precursor neoplasms and mature neoplasms. (1)Congenital leukemia and MPAL are both extremely rare. Furthermore, MPAL occurring in a neonate is even rarer. Congenital leukemia is diagnosed at birth or within the first month after birth and has an incidence of 1 in 5 million births (0.8% of all childhood leukemias). (2) MPAL consists of less than 5% of all pediatric acute leukemias. (3) Leukemia of mixed lineage is also known as “biphenotypic acute leukemia” (BAL). (4)Neonates with congenital leukemia can present with hepatosplenomegaly, petechiae, and ecchymosis. Affected newborns may have evidence of leukemic infiltration into the skin (leukemia cutis, appearing as a blueberry muffin rash) or lungs causing respiratory distress. (2)(5) In addition, neonates may have thrombocytopenia, anemia, and blasts seen on peripheral smear. (6) This patient had evidence of blueberry muffin rash and lymphocytosis with a monocyte predominance (blasts).The etiology of congenital leukemia is unknown, but genetic abnormalities, specifically the presence of KMT2A rearrangements, have been noted in 25% to 40% of cases. KMT2A gene rearrangements involve genetic rearrangements disrupting the lysine methyltransferase 2A gene on chromosome 11. Any rearrangement involving this gene results in a potent oncogene requiring very few other mutations to result in leukemia. (7) KMT2A gene rearrangements are seen in forms of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and MPAL. (8) Overall, congenital leukemia has a poor prognosis, and KMT2A translocations are a risk factor for poor outcomes. (9)MPAL is a subtype of acute leukemia that contains blast cells from multiple lineages. Possible combinations include B/T lymphoid, B/myeloid, T/myeloid, or B/T/myeloid. (4) This patient had a B/myeloid combination. Outcomes of MPAL are worse than those of both ALL and AML. (4) One of the treatment challenges unique to MPAL is how to approach the chemotherapy regimen: whether to target the ALL, target the AML, or target both using a hybrid treatment. This is still under study, but the literature shows that ALL therapy may be preferred as the initial therapy, leaving AML therapy for refractory cases. (10)(11)This patient was appropriate for gestational age without microcephaly, seizures, ocular abnormalities, no evidence of calcifications on head ultrasonography, negative maternal screening, negative postnatal testing (cytomegalovirus, enterovirus, parvovirus B19, herpes simplex virus), making several TORCH infections and Aicardi-Goutières syndrome unlikely. The rash was diffuse (inconsistent with rhabdomyosarcoma) and was not limited to the skin (inconsistent with Hashimoto-Pritzker disease). Hashimoto-Pritzker disease is a variant of Langerhans cell histiocytosis with features limited to the skin, and these cases typically regress spontaneously in weeks to months. (5)Know the clinical and laboratory features of congenital leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExanthemaInfant, NewbornHumans

Autor:innen und Institutionen

  • Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Texas Children's Hospital, Houston, TX.
  • Department of Pathology and Immunology, Texas Children's Hospital/Baylor College of Medicine, Houston, TX.

Zitieren

APA

Gonzales, D. N., Punia, J. N., & Patil, M. S. (2024). Neonate With a Diffuse Maculopapular and Nodular Rash. NeoReviews. https://doi.org/10.1542/neo.25-3-e232

Vancouver

Gonzales DN, Punia JN, Patil MS. Neonate With a Diffuse Maculopapular and Nodular Rash. NeoReviews. 2024. doi:10.1542/neo.25-3-e232

BibTeX
@article{Gonzales2024,
  author = {Gonzales, Danielle N and Punia, Jyotinder Nain and Patil, Monika S},
  title = {Neonate With a Diffuse Maculopapular and Nodular Rash},
  journal = {NeoReviews},
  year = {2024},
  doi = {10.1542/neo.25-3-e232}
}
Kostenlos starten →